Top Key Companies for Newborn Screening and Genetic Services Market: Trivitron Healthcare, MASIMO CORPORATION, Covidien Plc, Nemours KidsHealth, NJ.gov, Agilent Technologies, Ge Healthcare, PERKINELMER, Natus Medical Incorporated, Waters, Bio-Rad Laboratories, Ab Sciex LLC.
Global Newborn Screening and Genetic Services Market Research Report: 2026-2035 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global Newborn Screening and Genetic Services Market Overview And Scope:
The Global Newborn Screening and Genetic Services Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Newborn Screening and Genetic Services utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Newborn Screening and Genetic Services Market Segmentation
By Type, Newborn Screening and Genetic Services market has been segmented into:
Dry Blood Spot Tests
Hearing Screening Tests
Cchd Screening Tests
Other
By Application, Newborn Screening and Genetic Services market has been segmented into:
Clinical Laboratories
Hospitals
Other
Regional Analysis of Newborn Screening and Genetic Services Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Newborn Screening and Genetic Services Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Newborn Screening and Genetic Services market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Newborn Screening and Genetic Services market.
Top Key Companies Covered in Newborn Screening and Genetic Services market are:
Trivitron Healthcare
MASIMO CORPORATION
Covidien Plc
Nemours KidsHealth
NJ.gov
Agilent Technologies
Ge Healthcare
PERKINELMER
Natus Medical Incorporated
Waters
Bio-Rad Laboratories
Ab Sciex LLC
Key Questions answered in the Newborn Screening and Genetic Services Market Report:
1. What is the expected Newborn Screening and Genetic Services Market size during the forecast period, 2026-2035?
2. Which region is the largest market for the Newborn Screening and Genetic Services Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Newborn Screening and Genetic Services Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Newborn Screening and Genetic Services Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Newborn Screening and Genetic Services companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Newborn Screening and Genetic Services Markets?
7. How is the funding and investment landscape in the Newborn Screening and Genetic Services Market?
8. Which are the leading consortiums and associations in the Newborn Screening and Genetic Services Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Newborn Screening and Genetic Services Market by Type
5.1 Newborn Screening and Genetic Services Market Overview Snapshot and Growth Engine
5.2 Newborn Screening and Genetic Services Market Overview
5.3 Dry Blood Spot Tests
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Dry Blood Spot Tests: Geographic Segmentation
5.4 Hearing Screening Tests
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hearing Screening Tests: Geographic Segmentation
5.5 Cchd Screening Tests
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Cchd Screening Tests: Geographic Segmentation
5.6 Other
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Other: Geographic Segmentation
Chapter 6: Newborn Screening and Genetic Services Market by Application
6.1 Newborn Screening and Genetic Services Market Overview Snapshot and Growth Engine
6.2 Newborn Screening and Genetic Services Market Overview
6.3 Clinical Laboratories
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Clinical Laboratories: Geographic Segmentation
6.4 Hospitals
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Hospitals: Geographic Segmentation
6.5 Other
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Newborn Screening and Genetic Services Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Newborn Screening and Genetic Services Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Newborn Screening and Genetic Services Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 TRIVITRON HEALTHCARE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MASIMO CORPORATION
7.4 COVIDIEN PLC
7.5 NEMOURS KIDSHEALTH
7.6 NJ.GOV
7.7 AGILENT TECHNOLOGIES
7.8 GE HEALTHCARE
7.9 PERKINELMER
7.10 NATUS MEDICAL INCORPORATED
7.11 WATERS
7.12 BIO-RAD LABORATORIES
7.13 AB SCIEX LLC
Chapter 8: Global Newborn Screening and Genetic Services Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Dry Blood Spot Tests
8.2.2 Hearing Screening Tests
8.2.3 Cchd Screening Tests
8.2.4 Other
8.3 Historic and Forecasted Market Size By Application
8.3.1 Clinical Laboratories
8.3.2 Hospitals
8.3.3 Other
Chapter 9: North America Newborn Screening and Genetic Services Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Dry Blood Spot Tests
9.4.2 Hearing Screening Tests
9.4.3 Cchd Screening Tests
9.4.4 Other
9.5 Historic and Forecasted Market Size By Application
9.5.1 Clinical Laboratories
9.5.2 Hospitals
9.5.3 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Newborn Screening and Genetic Services Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Dry Blood Spot Tests
10.4.2 Hearing Screening Tests
10.4.3 Cchd Screening Tests
10.4.4 Other
10.5 Historic and Forecasted Market Size By Application
10.5.1 Clinical Laboratories
10.5.2 Hospitals
10.5.3 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Newborn Screening and Genetic Services Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Dry Blood Spot Tests
11.4.2 Hearing Screening Tests
11.4.3 Cchd Screening Tests
11.4.4 Other
11.5 Historic and Forecasted Market Size By Application
11.5.1 Clinical Laboratories
11.5.2 Hospitals
11.5.3 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Newborn Screening and Genetic Services Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Dry Blood Spot Tests
12.4.2 Hearing Screening Tests
12.4.3 Cchd Screening Tests
12.4.4 Other
12.5 Historic and Forecasted Market Size By Application
12.5.1 Clinical Laboratories
12.5.2 Hospitals
12.5.3 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Newborn Screening and Genetic Services Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Dry Blood Spot Tests
13.4.2 Hearing Screening Tests
13.4.3 Cchd Screening Tests
13.4.4 Other
13.5 Historic and Forecasted Market Size By Application
13.5.1 Clinical Laboratories
13.5.2 Hospitals
13.5.3 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Newborn Screening and Genetic Services Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Dry Blood Spot Tests
14.4.2 Hearing Screening Tests
14.4.3 Cchd Screening Tests
14.4.4 Other
14.5 Historic and Forecasted Market Size By Application
14.5.1 Clinical Laboratories
14.5.2 Hospitals
14.5.3 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Newborn Screening and Genetic Services Scope:
|
Report Data
|
Newborn Screening and Genetic Services Market
|
|
Newborn Screening and Genetic Services Market Size in 2025
|
USD XX million
|
|
Newborn Screening and Genetic Services CAGR 2025 - 2032
|
XX%
|
|
Newborn Screening and Genetic Services Base Year
|
2024
|
|
Newborn Screening and Genetic Services Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Trivitron Healthcare, MASIMO CORPORATION, Covidien Plc, Nemours KidsHealth, NJ.gov, Agilent Technologies, Ge Healthcare, PERKINELMER, Natus Medical Incorporated, Waters, Bio-Rad Laboratories, Ab Sciex LLC.
|
|
Key Segments
|
By Type
Dry Blood Spot Tests Hearing Screening Tests Cchd Screening Tests Other
By Applications
Clinical Laboratories Hospitals Other
|